Reaction mass of hydrogen [4-[4-(p-ethoxyanilino)-4'-[ethyl(m-sulphonatobenzyl)amino]benzhydrylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(m-sulphonatobenzyl)ammonium, monosodium salt and mono(4-(((E)-((E)-4-((4-(4-ethoxyphenylamino)phenyl)(4-(ethyl(4-sulfonatobenzyl)amino)phenyl)methylene)cyclohexa-2,5-dienylidene)(ethyl)ammonio)methyl)benzenesulfonate)sodium salt
|
943-287-6
|
|
|
REACH registration C&L
|
View details
|
1-(4-tert-Butyl-phenyl)-3-(4-methoxy-phenyl)-propane-1,3-diol
|
943-286-0
|
955359-35-0
|
Skin Irrit. 2
Aquatic Chronic 2
|
Notified C&L
|
View details
|
Reaction Mass of tetrasodium [mu-[[4,4'-[(3,3'-dihydroxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-hydroxynaphthalene-2,7-disulphonato]](8-)]]dicuprate(4-) and hydrogen [[4,4'-[(3,3'-dihydroxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-hydroxynaphthalene-2,7-disulphonato]](8-)]]dicuprate(4-)
|
943-289-7
|
|
|
REACH registration C&L
|
View details
|
L-Lysine, N2-[(1,1-dimethylethoxy)carbonyl]-N6-(1-methylethyl)-
|
812-219-6
|
66880-55-5
|
|
Notified C&L
|
View details
|
Condensation products of 4-dodecylphenol and formaldehyde, acetic derivs., reaction products with calcium hydroxide (PROPOSED)
|
943-288-1
|
|
Skin Irrit. 2
Eye Irrit. 2
Aquatic Chronic 2
|
Notified C&L
|
View details
|
3-Carbamoyl-1-D-ribofuranosylpyridinium chloride, triacetate (6CI)
|
812-220-1
|
109527-15-3
|
|
Notified C&L
|
View details
|
Homopolymer of 4,4'-methylenedicyclohexyl diisocyanate
|
943-291-8
|
|
Skin Sens. 1
Resp. Sens. 1
|
Notified C&L
|
View details
|
4-Chloro-2-(methylsulfonyl)benzoic acid
|
812-221-7
|
142994-03-4
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
2-(1,3-dioxoisoindolin-2-yl)ethane-1-sulfonamide
|
812-222-2
|
4443-23-6
|
|
REACH registration C&L
|
View details
|
1-(5-fluoro-2-iodophenyl)ethanone
|
812-223-8
|
914225-70-0
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
Poly(oxy-1,2-ethanediyl), .alpha.-(1-oxo-2- propenyl)-.omega.-methoxy- reaction products with N,N-Diethyl-1,3-propanediamine
|
943-293-9
|
|
Skin Irrit. 2
Eye Irrit. 2
|
Notified C&L
|
View details
|
D-Glucitol, 1,4:3,6-dianhydro-, 2,5-bis(2-methyl-2-propenoate)
|
812-224-3
|
108646-62-4
|
Skin Irrit. 2
Skin Sens. 1
Eye Irrit. 2
|
Notified C&L
|
View details
|
L-Citrulline DL-Malate
|
812-225-9
|
54940-97-5
|
|
Notified C&L
|
View details
|
Tetrahydrofuran - trichloromolybdenum (3:1)
|
812-226-4
|
31355-55-2
|
|
Notified C&L
|
View details
|
Chlorocarbonylhydrido[4,5-bis-(di-i-propylphosphinomethyl)acridine]ruthenium(II)
|
812-228-5
|
1101230-25-4
|
|
Notified C&L
|
View details
|
Hydroxy(1,5-cyclooctadiene)rhodium(I) dimer
|
812-229-0
|
73468-85-6
|
|
Notified C&L
|
View details
|
(1,3-Dimethyl-1H-imidazol-3-ium-2-yl)trihydroborate
|
812-230-6
|
1211417-77-4
|
|
Notified C&L
|
View details
|
di-tert-butyl[3,6-dimethoxy-2',4',6'-tris(propan-2-yl)-[1,1'-biphenyl]-2-yl]phosphane; {2'-amino-[1,1'-biphenyl]-2-yl}palladio methanesulfonate
|
812-231-1
|
1536473-72-9
|
|
Notified C&L
|
View details
|
calcium 2-((3-fluoro-3'-methoxy-[1,1'-biphenyl]-4-yl)carbamoyl)cyclopent-1-ene-1-carboxylate
|
812-232-7
|
1354012-90-0
|
Acute Tox. 4
Repr. 1A
Aquatic Chronic 4
|
Notified C&L
|
View details
|
1-(7-Amino-5-bromoindolin-1-yl)ethanone
|
812-233-2
|
133433-62-2
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
Bis(N,N-di-tert-butyl-1,4-diaza-1,3-butadienyl)cobalt
|
812-234-8
|
177099-51-3
|
Acute Tox. 3
Skin Irrit. 2
Skin Sens. 1
Eye Irrit. 2
Resp. Sens. 1
Muta. 2
Carc. 2
Aquatic Chronic 1
|
Notified C&L
|
View details
|
Propanenitrile, 3-[bis[3-(dimethylamino)propyl]amino]-
|
812-235-3
|
64971-37-5
|
Acute Tox. 4
Acute Tox. 2
Skin Corr. 1B
Aquatic Chronic 2
|
Notified C&L
|
View details
|
Styrene maleic anhydride resin, cumene end-capped, methoxypolyethyleneglycol ester, ammonium salt
|
812-236-9
|
1642846-37-4
|
|
Notified C&L
|
View details
|
2'-Deoxy-2',2'-difluro-d-cytidine-5'-o-[phenyl(benzoxy-l-alaninyl)] phosphate (S-isomer)
|
812-237-4
|
1562406-27-2
|
|
Notified C&L
|
View details
|
2,7-Naphthalenedisulfonic acid, 5-[[4-chloro-6-[[2-[[4-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]phenyl]sulfonyl]ethyl](2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, sodium salt (1:6)
|
943-299-1
|
|
|
Notified C&L
|
View details
|
Alcohols, C9-11-branched, ethoxylated
|
943-302-6
|
|
|
Notified C&L
|
View details
|
2-(Methylsulfonyl)-1-pyridin-3-ylethanone
|
812-239-5
|
27302-94-9
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
1-(4-Chlorophenyl)-2-(methylsulfonyl)ethanone
|
812-240-0
|
24437-48-7
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
Reaction products of diphenyl ether and 9-methylene nonadecane
|
943-303-1
|
|
|
REACH registration C&L
|
View details
|
Enzymatic hydrolysis products of Ophiopogon japonicus, Liliaceae, root
|
812-241-6
|
|
|
REACH registration C&L
|
View details
|
2-hydroxyethyl [(1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyl] carbonate
|
701-039-2
|
156324-78-6
|
|
REACH registration C&L
|
View details
|
Reaction mass of 14014-06-3 and 7789-20-0
|
943-305-2
|
|
|
Notified C&L
|
View details
|
Mixed Hexenes T-149OH
|
943-306-8
|
|
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
Muta. 1B
Carc. 1A
Repr. 2
STOT RE 2
|
Notified C&L
|
View details
|
Fullerenes C60/C70
|
943-307-3
|
131159-39-2
|
|
Notified C&L
|
View details
|
tetrahydro-2H-1,4-oxazine polymer with 3-methyl-1,5-pentanediyl diacrylate and N'-(3-aminopropyl)-N,N-dimethylpropane-1,3-diamine
|
943-308-9
|
|
Skin Irrit. 2
Skin Sens. 1
Eye Irrit. 2
Aquatic Chronic 3
|
Notified C&L
|
View details
|
Acryl resin B
|
812-242-1
|
223674-49-5
|
|
Notified C&L
|
View details
|
1-chloro-3-iodo-5-(trifluoromethyl)benzene
|
812-243-7
|
1189352-83-7
|
|
REACH registration C&L
|
View details
|
2,3,3,4,4-pentafluoro-5-methoxy-2,5-bis[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]tetrahydrofuran
|
812-244-2
|
957209-18-6
|
|
Notified C&L
|
View details
|
Cyclopropylacetic acid
|
812-246-3
|
5239-87-2
|
Acute Tox. 4
Skin Irrit. 2
Eye Dam. 1
STOT SE 3
|
Notified C&L
|
View details
|
6-Cyclopropylnicotinic acid
|
812-247-9
|
75893-75-3
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
(4AS,7AS)-TERT-BUTYL OCTAHYDRO-1H-PYRROLO[3,4-B]PYRIDINE-1-CARBOXYLATE
|
812-248-4
|
181141-40-2
|
Acute Tox. 4
Skin Sens. 1B
|
Notified C&L
|
View details
|
5-Chloro-3-fluoropyridine-2-carbaldehyde
|
812-250-5
|
214055-11-5
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
4-Trifluoromethyl-thiazole-2-carbaldehyde
|
812-251-0
|
354587-75-0
|
|
Notified C&L
|
View details
|
4H,5H,6H-pyrrolo[1,2-b]pyrazole-2-carboxylic acid
|
812-252-6
|
796729-03-8
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
Pyrazolo[1,5-a]pyridine-2-carbaldehyde
|
812-253-1
|
885275-10-5
|
|
Notified C&L
|
View details
|
1-METHYL-1H-INDAZOLE-6-CARBOXYLIC ACID
|
812-254-7
|
1031417-77-2
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
2-METHYL-2H-INDAZOLE-5-CARBOXYLIC ACID
|
812-255-2
|
1197943-94-4
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
(2S)-2-(3-BROMOPHENYL)PYRROLIDINE HCL
|
812-256-8
|
1391452-66-6
|
Acute Tox. 4
Skin Sens. 1B
|
Notified C&L
|
View details
|
(2R)-2-(3-BROMOPHENYL)PYRROLIDINE HCL
|
812-257-3
|
1391550-13-2
|
Acute Tox. 4
Skin Sens. 1B
|
Notified C&L
|
View details
|
[4-(8-chloro-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridin-11-ylidene)piperidin-1-yl]-(5-methylpyridin-3-yl)methanone
|
943-309-4
|
156523-04-5
|
|
REACH registration C&L
|
View details
|
Reaction mass of 5,5'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[3-methylsalicylic] acid, potassium salt, compound with 2,2',2''-nitrilotriethanol and potassium 5-amino-3-{[4-(2-{4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)diazenyl]-2-sulfophenyl}vinyl)-3-sulfophenyl]diazenyl}-4-hydroxy-7-sulfonaphthalene-2-sulfonate - 2,2',2''-nitrilotriethanol (1:1) and 3,3'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonic] acid, potassium salt, compound with 2,2',2''-nitrilotriethanol and 3,3'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[6-amino-4-hydroxynaphthalene-2-sulphonic] acid, potassium salt, compound with 2,2',2''-nitrilotriethanol
|
943-311-5
|
|
|
REACH registration C&L
|
View details
|
[No public or meaningful name is available]
|
943-312-0
|
|
Skin Irrit. 2
Eye Irrit. 2
Aquatic Chronic 3
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
943-313-6
|
|
Skin Irrit. 2
Eye Irrit. 2
Aquatic Chronic 3
|
Notified C&L
|
View details
|
Glucagon-like peptide II (2-glycine)
|
812-261-5
|
197922-42-2
|
|
Notified C&L
|
View details
|
(2S,5R)-5-((benzyloxy)amino)piperidine-2-carboxamide
|
812-263-6
|
1416134-49-0
|
|
Notified C&L
|
View details
|
(S)-N-((S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide
|
943-317-8
|
|
|
Notified C&L
|
View details
|
Reaction mass of 1330-20-7 and 25036-25-3
|
943-318-3
|
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Eye Irrit. 2
STOT SE 3
STOT RE 2
|
Notified C&L
|
View details
|
Reaction mass of 26265-08-7 and 67-64-1
|
943-319-9
|
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1B
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
Reaction mass of 25068-38-6 and 68609-97-2 and 9003-36-5
|
943-320-4
|
|
Skin Irrit. 2
Skin Sens. 1
Eye Irrit. 2
Aquatic Chronic 2
|
Notified C&L
|
View details
|
2-AMINO-1-PYRROLINE HYDROCHLORIDE
|
812-264-1
|
7544-75-4
|
|
Notified C&L
|
View details
|
ONION HYDROALCOHOLIC EXTRACT
|
943-324-6
|
|
Flam. Liq. 3
Skin Sens. 1
Eye Irrit. 2
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
812-266-2
|
202654-29-3
|
|
Notified C&L
|
View details
|
tert-Butyl 5-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate
|
812-267-8
|
216064-48-1
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
4-(BENZYLOXY)CYCLOHEXANONE
|
812-268-3
|
2987-06-6
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
3,3'-[ethylenebis[(3-sulpho-p-phenylene)azo]]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonic acid] hexasodium salt AND 3,3'-[ethylenebis[(3-sulpho-p-phenylene)azo]]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonic] acid, compound with 2,2',2''-nitrilotriethanol (1:6)
|
943-325-1
|
|
|
REACH registration C&L
|
View details
|
1,3-dipyridin-4-ylurea
|
812-269-9
|
39642-87-0
|
Acute Tox. 2
Acute Tox. 3
|
Notified C&L
|
View details
|
(4,6-dimethoxy-pyrimidin-2-yl)-[3-(2,2,2-trifluoro-ethoxy)-pyridin-2-yl]-amine
|
943-326-7
|
|
Acute Tox. 4
Aquatic Chronic 3
|
Notified C&L
|
View details
|
1-[2-(Amino)-1-(4-hydroxyphenyl)ehtyl]cyclohexanol
|
812-270-4
|
149289-29-2
|
|
REACH registration C&L
|
View details
|
Precipitate from tellurium containing acid solutions by copper metal cementation
|
943-528-5
|
|
Acute Tox. 3
Skin Irrit. 2
Skin Sens. 1
Eye Dam. 1
Acute Tox. 4
Resp. Sens. 1
Muta. 2
Carc. 1A
Repr. 1A
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 2
|
REACH registration C&L
|
View details
|
Platinum, carbonyl(eta4-2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane)- (9CI)
|
812-272-5
|
226921-57-9
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
|
Notified C&L
|
View details
|
Tris[(trimethylsilyl)methylene]aluminium(III)
|
812-273-0
|
41924-27-0
|
Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B
Eye Dam. 1
|
Notified C&L
|
View details
|
Bis(mesityloxide)ruthenium(II)
|
812-274-6
|
857678-47-8
|
Flam. Sol. 1
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
Rhodium(III) hydroxide hydrate
|
812-275-1
|
120824-04-6
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
Bis(trifluoroacetato)[(S)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl]ruthenium(II)
|
812-276-7
|
106681-16-7
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
Chloro[1,3-bis(2,6-diisopropylphenyl)imidazole-2-ylidene]gold(I)
|
812-277-2
|
852445-81-9
|
Flam. Sol. 1
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
Tetrakis(1-methyl-1-propanolato)tungsten(VI) oxide
|
812-278-8
|
1676078-32-2
|
Flam. Liq. 3
Water-react. 1
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
Dihydrogen bisoxalatoplatinate(II)
|
812-279-3
|
83771-84-0
|
Met. Corr. 1
Acute Tox. 4
Acute Tox. 4
Skin Corr. 1C
Eye Dam. 1
Acute Tox. 4
|
Notified C&L
|
View details
|
[(r)-(-)-1-[(s)-2-(diphenylphosphino)-ferrocenyl]-ethyldi-tert.butylphosphine-(1,5-cyclooctadiene)-rhodium(I)]-tetrafluoroborate
|
812-280-9
|
673458-86-1
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Dam. 1
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
Dirhodium(II) tetrakisacetate hydrate
|
812-281-4
|
29998-99-0
|
Flam. Sol. 1
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
Rhodium oxide (Rh2O3), pentahydrate
|
812-283-5
|
39373-27-8
|
|
Notified C&L
|
View details
|
Chloro[(1,2,3-η)-1-phenyl-2-propen-1-yl]-{[1,3-bis[2,6-bis(diphenylmethyl)-4-methylphenyl]-2H-imidazol-2-ylidene}palladium(II), min. 97%
|
812-284-0
|
1380314-24-8
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
chloro[(S)-2,2´-bis(bis(3,5-dimethylphenyl)phosphino)-1,1´-binaphthyl](p-cymene)ruthenium(II) chloride
|
812-285-6
|
1345887-44-6
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
[N-[(1R,2R)-2-(amino-κN)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-κN]chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl]-rhodium Stereoisomer
|
812-286-1
|
223392-99-2
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
Reaction mass of bis[2-[2-(2-butoxyethoxy)ethoxy]ethyl] adipate and [2-[2-(2-butoxyethoxy)ethoxy]ethyl] 3,6,9,12-tetraoxahexadec-1-yl adipate
|
943-330-9
|
|
|
REACH registration C&L
|
View details
|
(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
|
812-287-7
|
1192651-49-2
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[2-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt, sodium salt
|
812-288-2
|
115970-66-6
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
3-Butyl-2-[5-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-penta-1,3-dienyl]-1,1-dimethyl-1H-benzo[e]indolium tetrafluoroborate
|
812-289-8
|
172491-72-4
|
|
Notified C&L
|
View details
|
3-Butyl-2-[5-(1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)-penta-1,3-dienyl]-1,1-dimethyl-1H-benzo[e]indolium perchlorate
|
812-290-3
|
173894-27-4
|
|
Notified C&L
|
View details
|
H-Cys(1)-Cys(2)-Glu-Tyr-Cys(3)-Cys(1)-Asn-Pro-Ala-Cys(2)-Thr-Gly-Cys(3)-Tyr-OH
|
812-291-9
|
851199-59-2
|
|
Notified C&L
|
View details
|
1-Bromo-2-phenoxy-benzene
|
812-295-0
|
7025-06-1
|
Acute Tox. 4
Acute Tox. 4
Acute Tox. 4
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[2-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-1,3,3-trimethyl-3H-indolium 4-methylbenzenesulfonate
|
812-296-6
|
205744-92-9
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[2-(3-ethyl-1,3-dihydro-1,1-dimethyl-2H-benzo[e]indol-2-ylidene)-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-3-ethyl-1,1-dimethyl-1H-benzo[e]indolium tetrafluoroborate
|
812-297-1
|
193687-63-7
|
|
Notified C&L
|
View details
|
reaction mass of 1,1,1,2,2,3,3,4,4,5,5,6,6,6-tetradecafluoro-hexane and 1,1,1,2,2,3,3,4,5,5,5-undecafluoro-4-(trifluoromethyl)pentane
|
943-336-1
|
|
|
Notified C&L
|
View details
|
Pyridinium, 4-formyl-1-methyl-
|
812-298-7
|
13441-53-7
|
|
Notified C&L
|
View details
|
(1-Cyanomethyl-cyclopropyl)-acetonitrile
|
812-299-2
|
20778-47-6
|
|
Notified C&L
|
View details
|
4-Fluorobenzofuran
|
812-300-6
|
24410-58-0
|
|
Notified C&L
|
View details
|
Sodium ethanesulfinate
|
812-301-1
|
20035-08-9
|
|
Notified C&L
|
View details
|
(R)-Pyrrolidine-3-carboxamide hydrochloride
|
812-302-7
|
1273577-42-6
|
|
Notified C&L
|
View details
|
3-Bromo-2-methylphenol
|
812-303-2
|
7766-23-6
|
|
Notified C&L
|
View details
|
Di-tert-butyl L-glutamate hydrochloride
|
812-304-8
|
32677-01-3
|
|
Notified C&L
|
View details
|
N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-methyl-L-tyrosine
|
812-305-3
|
77128-72-4
|
|
Notified C&L
|
View details
|
Fmoc-L-3-methylphenylalanine
|
812-306-9
|
211637-74-0
|
|
Notified C&L
|
View details
|
(2S)-3-(4-cyanophenyl)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid
|
812-307-4
|
173963-93-4
|
|
Notified C&L
|
View details
|
4-pyrazol-1-yl-pyridine HCl
|
943-337-7
|
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
Reaction products resulting from the esterification of C18 unsaturated fatty acid with glycerol and glycerol oligomers
|
943-350-8
|
|
|
REACH registration C&L
|
View details
|
[5-(trifluoromethyl)pyridin-2-yl]methanol
|
812-309-5
|
31181-84-7
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2A
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
1-(Tetrahydropyran-2-yl)pyrazole-5-boronic acid
|
812-310-0
|
1105511-68-9
|
|
Notified C&L
|
View details
|
2-(Methoxycarbonylmethyl)phenylboronic acid pinacol ester
|
812-311-6
|
956229-86-0
|
|
Notified C&L
|
View details
|
1,7-Diaza-spiro[4.4]nonane-1-carboxylic acid tert-butyl ester
|
812-312-1
|
885268-47-3
|
|
Notified C&L
|
View details
|
1,3-Benzothiazole-2-carboxylic acid hydrate
|
812-313-7
|
3622-04-6
|
|
Notified C&L
|
View details
|
6-Chloro-N4-cyclopropylpyrimidine-2,4-diamine
|
812-314-2
|
1158781-49-7
|
|
Notified C&L
|
View details
|
3-fluoro-1H-pyrazole
|
812-315-8
|
14521-81-4
|
|
Notified C&L
|
View details
|
Reaction mass of 4-methylene-2-phenyltetrahydro-2H-pyran and 4-methyl-2-phenyl-3,6-dihydro-2H-pyran
|
943-338-2
|
|
|
REACH registration C&L
|
View details
|
1-(3-Methyl-2-pyridinyl)piperazine
|
812-316-3
|
104396-10-3
|
|
Notified C&L
|
View details
|
1-Methyl-1H-pyrazol-4-ylamine hydrochloride
|
812-317-9
|
127107-23-7
|
|
Notified C&L
|
View details
|
3-(Methylthio)-5-(trifluoromethyl)benzeneboronic acid
|
812-318-4
|
957120-83-1
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[[1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benzo[e]indol-2-ylidene]-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-1,1-dimethyl-3-(4-sulfobutyl)-1H-benzo[e]indolium hydroxide, inner salt, sodium salt
|
812-320-5
|
172616-80-7
|
|
Notified C&L
|
View details
|
3-Butyl-2-[5-(3-butyl-1,3-dihydro-1,1-dimethyl-2H-benzo[e]indol-2-ylidene)-penta-1,3-dienyl]-1,1-dimethyl-1H-benzo[e]indolium perchlorate
|
812-321-0
|
121482-73-3
|
|
Notified C&L
|
View details
|
Ethyl 2-(4-(t-BOC)piperazin-1-yl)-4-hydroxypyrimidine-5-carboxylate
|
812-322-6
|
1065074-31-8
|
|
Notified C&L
|
View details
|
1,3-Dimethyl-2,6-dioxo-5-(2-(2-(1,3,3-trimethyl-3H-indolium-2-yl)vinyl)-5-(2-(1,3,3-trimethylindolin-2-ylidene)ethylidene)cyclopent-1-en-1-yl)-1,2,3,6-tetrahydropyrimidin-4-olate
|
812-323-1
|
256520-09-9
|
|
Notified C&L
|
View details
|
3-Butyl-2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-propenyl]-1,1-dimethyl-1H-benzo[e]indolium perchlorate
|
812-324-7
|
214706-06-6
|
|
Notified C&L
|
View details
|
3-Butyl-2-[5-(3-butyl-1,3-dihydro-1,1-dimethyl-2H-benzo[e]indol-2-ylidene)-3-chloro-penta-1,3-dienyl]-1,1-dimethyl-1H-benzo[e]indolium hexafluorophosphate
|
812-325-2
|
354540-12-8
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[2-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-ethylidene]-1-cyclopenten-1-yl]-ethenyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt, sodium salt
|
812-326-8
|
757960-10-4
|
|
Notified C&L
|
View details
|
2-[5-[1-(5-Carboxypentyl)-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-penta-1,3-dienyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt, sodium salt
|
812-327-3
|
666829-22-7
|
|
Notified C&L
|
View details
|
2-[3-(1,3-Dihydro-1,1,3-trimethyl-2H-benzo[e]indol-2-ylidene)-propenyl]-1,1,3-trimethyl-1H-benzo[e]indolium perchlorate
|
812-328-9
|
74276-27-0
|
|
Notified C&L
|
View details
|
2-(3-amino-5-methoxy-phenoxy)ethanol
|
812-329-4
|
725237-16-1
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[2-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-1,3,3-trimethyl-3H-indolium chloride
|
812-331-5
|
199444-11-6
|
|
Notified C&L
|
View details
|
2-Amino-5-bromo-4-fluoro-benzoic acid
|
812-332-0
|
143945-65-7
|
|
Notified C&L
|
View details
|
(2-Chlorothiazol-5-yl)methylamine
|
812-333-6
|
120740-08-1
|
|
Notified C&L
|
View details
|
Reaction products of Nitrilotri(methylphosphonic acid) and hydrogen peroxide
|
943-339-8
|
|
|
REACH registration C&L
|
View details
|
2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)acetic acid
|
812-334-1
|
942132-30-1
|
Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
STOT SE 3
Repr. 2
Aquatic Acute 1
|
Notified C&L
|
View details
|
2-(2-(4-((2-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid
|
812-335-7
|
83881-59-8
|
Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
STOT SE 3
Repr. 2
Aquatic Acute 1
|
Notified C&L
|
View details
|
4-(Aminomethyl)-3-fluorophenylboronic acid, HCl
|
812-336-2
|
1072946-45-2
|
|
Notified C&L
|
View details
|
C18unsatd. fatty acids reaction products with N-(2-hydroxy)propylamine
|
943-345-0
|
|
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
|
REACH registration C&L
|
View details
|
N-Cyclopropyl-N'-hydroxyguanidine hydrochloride
|
812-337-8
|
551935-92-3
|
|
Notified C&L
|
View details
|
Di-t-butylmethylsilane
|
812-338-3
|
56310-20-4
|
|
Notified C&L
|
View details
|
dibenzylbenzene, ar-methyl derivative, hydrogenated
|
943-342-4
|
|
|
REACH registration C&L
|
View details
|
Mixed octenes T-149OH
|
943-344-5
|
|
Flam. Liq. 2
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
Muta. 1B
Carc. 1A
Aquatic Chronic 2
|
Notified C&L
|
View details
|
1,3-Dimethyl-5-[2-(3-methyl-oxazolidin-2-ylidene)-ethylidene]-pyrimidine-2,4,6-trione
|
812-339-9
|
428519-06-6
|
|
Notified C&L
|
View details
|
1,3-Dimethyl-5-[2-(1-methyl-pyrrolidin-2-ylidene)-ethylidene]-pyrimidine-2,4,6-trione
|
812-340-4
|
428519-09-9
|
|
Notified C&L
|
View details
|
2-[3-(1,3-Dihydro-1,1,3-trimethyl-2H-benzo[e]indol-2-ylidene)-propenyl]-1,1,3-trimethyl-1H-benzo[e]indolium hexafluorophosphate
|
812-342-5
|
599177-24-9
|
|
Notified C&L
|
View details
|
1-Butyl-5-[2-(1-butyl-3,3-dimethyl-1,3-dihydro-indol-2-ylidene)-ethylidene]-4-methyl-2,6-dioxo-1,2,5,6-tetrahydro-pyridine-3-carbonitrile
|
812-343-0
|
233748-97-5
|
|
Notified C&L
|
View details
|
3-Butyl-2-(2-[3-[2-(3-butyl-1,1-dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-ethylidene]-2-chloro-cyclohex-1-enyl]-vinyl)-1,1-dimethyl-1H-benzo[e]indolium hexafluorophosphate
|
812-344-6
|
885691-99-6
|
|
Notified C&L
|
View details
|
1,3,3-Trimethyl-2-(2-[2-phenylsulfanyl-3-[2-(1,3,3-trimethyl-1,3-dihydro-indol-2-ylidene)-ethylidene]-cyclohex-1-enyl]-vinyl)-3H-indolium chloride
|
812-345-1
|
269401-43-6
|
|
Notified C&L
|
View details
|
1-Butyl-2-[5-(1-butyl-1H-benzo[cd]indol-2-ylidene)-penta-1,3-dienyl]-benzo[cd]indolium tetrafluoroborate
|
812-346-7
|
1135933-68-4
|
|
Notified C&L
|
View details
|
1-Butyl-2-(2-[3-[2-(1-butyl-3,3-dimethyl-1,3-dihydro-indol-2-ylidene)-ethylidene]-2-chloro-cyclohex-1-enyl]-vinyl)-3,3-dimethyl-3H-indolium hexafluorophosphate
|
812-347-2
|
885691-97-4
|
|
Notified C&L
|
View details
|
3-[2-(5-tert-Butyl-benzooxazol-2-yl)-vinyl]-9-ethyl-9H-carbazole
|
812-348-8
|
946155-08-4
|
|
Notified C&L
|
View details
|
1,1,6,6,8-Pentamethyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one
|
812-349-3
|
113869-04-8
|
|
Notified C&L
|
View details
|
1,3,3-Trimethyl-2-[5-(1,3,3-trimethyl-1,3-dihydro-indol-2-ylidene)-penta-1,3-dienyl]-3H-indolium chloride
|
812-350-9
|
54268-70-1
|
|
Notified C&L
|
View details
|
1-Butyl-2-(2-[5-tert-butyl-3-[2-(1-butyl-1H-benzo[cd]indol-2-ylidene)-ethylidene]-2-phenyl-cyclohex-1-enyl-vinyl)-benzo[cd]indolium tetrafluoroborate
|
812-351-4
|
1020561-22-1
|
|
Notified C&L
|
View details
|
Phenol, dimethyl-, polymer with formaldehyde and methylphenol
|
812-353-5
|
9065-82-1
|
|
Notified C&L
|
View details
|
2,2,2-Trifluoro-1-(4-isocyanatopiperidin-1-yl)ethanone
|
812-354-0
|
493036-44-5
|
Acute Tox. 3
Acute Tox. 3
Acute Tox. 3
|
Notified C&L
|
View details
|
1-Butyl-2-(2-[3-[2-(1-butyl-1H-benzo[cd]indol-2-ylidene)-ethylidene]-2-diphenylamino-cyclopent-1-enyl]-vinyl)-benzo[cd]indolium tetrafluoroborate
|
812-355-6
|
1289375-52-5
|
|
Notified C&L
|
View details
|
1-Butyl-2-(2-[3-[2-(1-butyl-3,3-dimethyl-1,3-dihydro-indol-2-ylidene)-ethylidene]-2-diphenylamino-cyclopent-1-enyl]-vinyl)-3,3-dimethyl-3H-indolium tetrafluoroborate
|
812-356-1
|
1888324-74-0
|
|
Notified C&L
|
View details
|
1-Butyl-2-[7-(1-butyl-1H-benzo[cd]indol-2-ylidene)-hepta-1,3,5-trienyl]-benzo[cd]indolium hexafluorophosphate
|
812-357-7
|
1610514-96-9
|
|
Notified C&L
|
View details
|
Phosphorotetrathioic acid, trilithium salt
|
812-358-2
|
82857-67-8
|
Flam. Sol. 1
Water-react. 1
Acute Tox. 3
Skin Corr. 1B
Eye Dam. 1
Acute Tox. 4
Aquatic Acute 1
|
Notified C&L
|
View details
|
Lithium Phosphorous Sulfide Iodide (7:2:8:1)
|
943-346-6
|
|
Flam. Sol. 1
Water-react. 1
Acute Tox. 3
Skin Corr. 1B
Eye Dam. 1
Acute Tox. 4
Aquatic Acute 1
|
Notified C&L
|
View details
|
1,1,6,6-Tetramethyl-10-oxo-2,3,5,6-tetrahydro-1H,4H,10H-11-oxa-3a-aza-benzo[de]anthracene-9-carbonitrile
|
812-359-8
|
115662-11-8
|
|
Notified C&L
|
View details
|
10,11,14,15-Tetrahydro-6-imino-9,9,15,15-tetramethyl-6H,9H,13H-benzimidazo[1'',2'':1',2']pyrido[4',3':2,3][1]benzopyrano[6,7,8-ij]quinolizine-7-carbonitrile
|
812-360-3
|
203381-28-6
|
|
Notified C&L
|
View details
|
(S)-2-(TERT-BUTOXYCARBONYLAMINO)-3-[4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL]PROPANOIC ACID
|
812-361-9
|
216439-76-8
|
|
Notified C&L
|
View details
|
1-(2-BROMO-4-CHLOROPHENYL)-2,2,2-TRIFLUOROETHANONE
|
812-362-4
|
1033805-23-0
|
|
Notified C&L
|
View details
|
4-[2-AMINO-6-[(1R)-1-[4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL]-2,2,2-TRIFLUOROETHOXY]-4-PYRIMIDINYL]-, ETHYL ESTER
|
812-364-5
|
1137608-69-5
|
|
Notified C&L
|
View details
|
2-[2-(3-[2-[3,3-Dimethyl-5-sulfo-1-(4-sulfobutyl)-1,3-dihydro-indol-2-ylidene]-ethylidene]-2-phenyl-cyclohex-1-enyl)-vinyl]-3,3-dimethyl-5-sulfo-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt, trisodium salt
|
812-365-0
|
897625-36-4
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[[1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benzo[e]indol-2-ylidene]-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-1,1-dimethyl-3-(4-sulfobutyl)-1H-benzo[e]indolium hydroxide, inner salt, triethylammonium salt
|
812-366-6
|
289893-03-4
|
|
Notified C&L
|
View details
|
4-(2-Fluorophenyl)-5-methylene-1H-pyrrol-2(5H)-one
|
943-348-7
|
|
|
Notified C&L
|
View details
|
1,1,5,5-Tetrahydroperfluoropentyl-1,5-dimethacrylate
|
812-367-1
|
918-36-5
|
|
Notified C&L
|
View details
|
2-Methyl-4-oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxylic acid
|
812-368-7
|
1114596-35-8
|
|
Notified C&L
|
View details
|
2-Isopropyl-4-methylthiazole-5-boronic acid, pinacol ester
|
812-369-2
|
1218789-55-9
|
|
Notified C&L
|
View details
|
2-(2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethoxy)acetic Acid
|
812-370-8
|
682323-77-9
|
Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
STOT SE 3
Repr. 2
Aquatic Acute 1
|
Notified C&L
|
View details
|
2-(2-(4-benzhydrylpiperazin-1-yl)ethoxy) acetic acid
|
812-371-3
|
83881-53-2
|
Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
STOT SE 3
Repr. 2
Aquatic Acute 1
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
|
|
Aquatic Acute 1
Aquatic Chronic 1
|
Notified C&L
|
View details
|
6-Chloroindole-2-boronic acid, pinacol ester
|
812-372-9
|
912331-84-1
|
|
Notified C&L
|
View details
|
N-alpha-(9-Fluorenylmethyloxycarbonyl)-D-aspartic acid alpha-t-butyl ester
|
812-373-4
|
134098-70-7
|
|
Notified C&L
|
View details
|
Boc-D-4-Thiazolylalanine
|
812-375-5
|
134107-69-0
|
|
Notified C&L
|
View details
|
Fmoc-D-4-Thiazolylalanine
|
812-376-0
|
205528-33-2
|
|
Notified C&L
|
View details
|
(dimethoxy(methyl)silyl)methanamine
|
812-377-6
|
343926-26-1
|
Flam. Liq. 3
Skin Corr. 1B
Eye Dam. 1
|
REACH registration C&L
|
View details
|
[No public or meaningful name is available]
|
|
|
Aquatic Acute 1
Aquatic Chronic 1
|
Notified C&L
|
View details
|
1-Decanaminium,N-decyl-N,N-dimethyl-, hexanedioate(2:1)
|
812-378-1
|
210420-85-2
|
Acute Tox. 4
Skin Corr. 1B
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
Notified C&L
|
View details
|
Chloro(pentamethylcyclopentadienyl){5-cyano-2-{1-[(4-methoxyphenyl)imino-kN]ethyl}phenyl-kC}iridium(III)
|
812-379-7
|
1258964-46-3
|
|
Notified C&L
|
View details
|
Chloro(pentamethylcyclopentadienyl){5-methoxy-2-{1-[(4-methoxyphenyl)imino-kN]ethyl}phenyl-kC}iridium(III
|
812-380-2
|
1258964-48-5
|
|
Notified C&L
|
View details
|
4-(1H-pyrazol-1-yl)aniline hydrochloride
|
812-381-8
|
913848-94-9
|
|
Notified C&L
|
View details
|
Chloro(pentamethylcyclopentadienyl){5-nitro-2-{1-[(4-methoxyphenyl)imino-kN]ethyl}phenyl-kC}iridium(III)
|
812-382-3
|
1439402-25-1
|
|
Notified C&L
|
View details
|
4-Oxo-hexahydro-cyclopenta[c]pyrrole-2-carboxylic acid tert-butyl ester
|
812-383-9
|
130658-14-9
|
|
Notified C&L
|
View details
|
3-(Methylsulfonyl)propanoic acid
|
812-384-4
|
645-83-0
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
2-(Diisopropylphosphino)ethanamine - dichlororuthenium (2:1)
|
812-386-5
|
1092372-90-1
|
|
Notified C&L
|
View details
|
Chlorodihydrido[bis[(2-diisopropylphosphino)ethyl]amine]iridium
|
812-387-0
|
791629-96-4
|
|
Notified C&L
|
View details
|
1,3-Dimethyl-4-phenyl-1H-pyrazol-5-amine
|
812-388-6
|
3654-22-6
|
|
Notified C&L
|
View details
|
1-(2-Chloroethyl)-1H-pyrazole
|
812-389-1
|
96450-53-2
|
|
Notified C&L
|
View details
|
5-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine
|
812-390-7
|
1222533-84-7
|
|
Notified C&L
|
View details
|
3-(4-Fluorophenyl)-1-methyl-1H-pyrazol-5-amine
|
812-391-2
|
126417-81-0
|
|
Notified C&L
|
View details
|
Oxazole-2-carbonitrile
|
812-392-8
|
68776-60-3
|
|
Notified C&L
|
View details
|
4,5-Dimethyl-isoxazole-3-carboxylic acid
|
812-393-3
|
100047-61-8
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
|
|
Aquatic Acute 1
Aquatic Chronic 1
|
Notified C&L
|
View details
|
4-Iodo-3-methylbenzonitrile
|
812-394-9
|
42872-85-5
|
|
Notified C&L
|
View details
|
2,4-dimethylpyrimidin-5-amine
|
812-395-4
|
35733-53-0
|
Acute Tox. 4
Skin Irrit. 2
Eye Dam. 1
STOT SE 3
|
Notified C&L
|
View details
|
Adamantane-1-carbohydrazide
|
812-397-5
|
17846-15-0
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
|
|
Aquatic Acute 1
Aquatic Chronic 1
|
Notified C&L
|
View details
|
4-[3-Chloro-4-(N’-cyclopropylureido) phenoxy]-7-methoxyquinoline-6-carboxamide (.methanesulfonate)
|
812-398-0
|
857890-39-2
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
|
|
Aquatic Acute 1
Aquatic Chronic 1
|
Notified C&L
|
View details
|
4-Chloro-1-methyl-1H-indole-2-carboxylic acid
|
812-399-6
|
23967-44-4
|
|
Notified C&L
|
View details
|
|
|
|
|
|
|